MedPath

Implant stability change for one-year postoperative stage after simultaneous implant placement with sinus graft for maxillary posterior region: Randomized clinical comparative study of PRF versus Bio-Oss

Not Applicable
Conditions
Missing tooth
Registration Number
JPRN-UMIN000021342
Lead Sponsor
Faculty of Dental Science, Kyushu University
Brief Summary

In this study, we randomly selected PRF or Bio-Oss for simultaneous implant placement with sinus graft and conducted a 9-12month follow-up observation. Our results indicated good outcomes, with a survival rate of 100% in the PRF group and 95.2% in the Bio-Oss group. A stability dip in ISQ values was also noted in both groups at 2 weeks after implant placement. The stability dip was mild in the PRF group and ISQ values were observed to be identical in the two groups at several time-points. Thus, together with the good survival rate achieved, we confirmed the efficacy of PRF. In the future, further follow-up observation of research patients needs to be conducted.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

(1) having systemic or psychiatric disease that could affect implant treatment, (2) contradiction to oral surgical procedures, (3) participants to other clinical trials, (4) heavy bruxers or having clenching habit, (5) already undergone bone augmentation in the implant site, (6) having an untreated tooth or teeth requiring endodontic treatment adjacent to the implant placement site, (7) having teeth with 4 mm or deeper periodontal pockets, (8) smoking 10 or more cigarettes per day or were unable to quit smoking for the two weeks before and after implant placement, (9) pregnant or breastfeeding, (10) considered unsuitable to participate in the study by their physician-in-charge, (11) having an experience of the failure of implant placement at the concerned site, (12) undergone tooth extraction within the past 12 weeks.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
implant stability quotient (ISQ) at implant placement, 1 week, 2 week, 1, 2, 3, 6 and 12 months
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath